Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19-Reference-Cited by-同舟云学术

Evaluation of autoantibody profile in healthy subjects after mRNA vaccination against COVID-19

Published:2023-09 Issue: Volume:122 Page:110592
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Fiorelli Denise^ORCID,Caruso Vincenza^ORCID,Belardi Riccardo^ORCID,Bernardini Sergio,Nuccetelli Marzia^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference36 articles.

1. A novel coronavirus genome identified in a cluster of pneumonia cases - Wuhan, China 2019–2020;Tan;China CDC Wkly,2020

2. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

4. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N. Engl. J. Med.,2020

5. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines;Meo;Eur. Rev. Med. Pharmacol. Sci.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic P2X7R expressed on regulatory T cells potentially links molecular mimicry to autoimmune responses;AIMS Allergy and Immunology;2024

2. Transient Autoreactive PF4 and Antiphospholipid Antibodies in COVID-19 Vaccine Recipients;Vaccines;2023-12-14

3. Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein Microarrays;Vaccines;2023-11-07